Holen Sie sich die Stockscreener-App
91.42
0.06%
-0.09
Schlusskurs vom Vortag:
$91.51
Offen:
$91.72
24-Stunden-Volumen:
58,717
Relative Volume:
0.68
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.28%
1M Leistung:
+6.32%
6M Leistung:
+6.44%
1J Leistung:
+43.80%
1-Tages-Spanne:
$90.88
$92.00
1-Wochen-Bereich:
$88.70
$92.00
52-Wochen-Spanne:
$63.76
$92.30
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
91.42 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.57 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
750.58 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
754.14 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
292.98 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
730.42 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
Precision Trading with Ishares U.s. Pharmaceuticals Etf (IHE) Risk Zones - Stock Traders Daily
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
iShares U.S. Pharmaceuticals ETF outperforms despite drug pricing policy risks, up 38% in 12 months. - Pluang
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices? - 24/7 Wall St.
Should you invest in the iShares US Pharmaceuticals ETF (IHE)? - MSN
Healthcare sector undervalued, with iShares U.S. Pharmaceuticals ETF leading gains but risks from concentration exist. - Pluang
IHE: Healthcare Dashboard For May - Seeking Alpha
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics - The Globe and Mail
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
FDA commissioner raises concerns about US pharma lagging behind China in drug development - MSN
7 ETFs to Play a Healthcare Rebound - Barron's
Healthcare Is Due for a Rebound. These ETFs Are a Good Way to Buy In. - Barron's
IHE: As AI Speeds Drug Research, this Pharmaceutical ETF Should Prosper - moneyshow.com
(05/04/26) IHE: As AI Speeds Drug Research, this Pharmaceutical ETF Should - moneyshow.com
IHE- As AI Speeds Drug Research, this Pharmaceutical ETF Should Prosper - Yahoo Finance
The pharmaceutical sector is surging. Here's 1 stock every investor should have on their radar. - MSN
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)? - Yahoo Finance
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? - Yahoo Finance
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move - MSN
iShares US Pharmaceuticals ETF declares quarterly distribution of $0.2845 - MSN
Should You Invest in the iShares U.S. Healthcare ETF (IYH)? - Yahoo Finance
What Johnson & Johnson Earnings Signal for Healthcare ETFs - ETF Trends
iShares U.S. Pharmaceuticals ETF (IHE) - Minichart
Anfield US Equity Sector Rotation ETF's iShares U.S. Pharmaceuticals ETF(IHE) Holding History - GuruFocus
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report - Stocktwits
Stock List: Research Stocks from Around the World - GuruFocus
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything - The Motley Fool
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - 24/7 Wall St.
With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize - AOL.com
Is the Invesco Pharmaceuticals ETF (PJP) Currently a Top ETF Choice? - Bitget
Should you consider putting your money into the iShares U.S. Pharmaceuticals ETF (IHE)? - Bitget
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development - Stocktwits
PPH, IHE, PJP: U.S. Pharmaceutical ETFs Offer Investors Innovation and Growth - TipRanks
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):